The disease burden of human papillomavirus in men is substantial and can potentially be prevented

Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection. High-risk HPV causes penile cancer and a substantial proportion of oropharyngeal and anal malignancy in men. Low-risk types of HPV cause anogenital warts. The incidence of oropharyngeal and anal cancers is increasing in...

Full description

Saved in:
Bibliographic Details
Published inUgeskrift for læger Vol. 175; no. 6; p. 349
Main Authors Kiellberg Larsen, Helle, Kofoed, Kristian, Sand, Carsten
Format Journal Article
LanguageDanish
Published Denmark 04.02.2013
Subjects
Adolescent
Anus Neoplasms - epidemiology
Anus Neoplasms - prevention & control
Anus Neoplasms - virology
Buschke-Lowenstein Tumor - pathology
Condylomata Acuminata - epidemiology
Condylomata Acuminata - prevention & control
Condylomata Acuminata - virology
Cost of Illness
Denmark - epidemiology
Female
Homosexuality, Male
Humans
Immunization Programs
Male
Oropharyngeal Neoplasms - epidemiology
Oropharyngeal Neoplasms - prevention & control
Oropharyngeal Neoplasms - virology
Papillomavirus Infections - complications
Papillomavirus Infections - epidemiology
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines
Penile Neoplasms - epidemiology
Penile Neoplasms - pathology
Penile Neoplasms - prevention & control
Penile Neoplasms - virology
Young Adult
Denmark
Online AccessGet more information

Cover

More Information
Summary:Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection. High-risk HPV causes penile cancer and a substantial proportion of oropharyngeal and anal malignancy in men. Low-risk types of HPV cause anogenital warts. The incidence of oropharyngeal and anal cancers is increasing in Denmark. Prevention of penile, anal and oropharyngeal cancers and anogenital warts represents potential benefits of the HPV vaccine; and vaccination of men is now recommended by the Australian and the North American health authorities. Thus, we recommend that the Danish HPV vaccination program should include men.
ISSN:1603-6824